DJ Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ inched 0.11% higher to $17.84 Monday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.97% to 19,403.95 and the Dow Jones Industrial Average falling 0.29% to 44,782.00.
This was the stock's second consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed $44.06 short of its 52-week high ($61.90), which the company achieved on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 2.14% to $5.04, Fortress Biotech Inc. (FBIO) rose 7.98% to $2.30, and Viking Therapeutics Inc. $(VKTX)$ fell 2.70% to $51.51.
Trading volume (273,245) remained 254,456 below its 50-day average volume of 527,701.
Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 02, 2024 17:24 ET (22:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments